P
US11608366B2ActiveUtilityPatentIndex 58

Recombinant vector and method for producing recombinant fibroblast growth factor 19 using the same

Assignee: UNIV NAT CHONNAM IND FOUNDPriority: May 13, 2020Filed: Aug 19, 2020Granted: Mar 21, 2023
Est. expiryMay 13, 2040(~13.9 yrs left)· nominal 20-yr term from priority
Inventors:KIM GEUN-JOONGCHOI HYE JICHEONG DAE EUNYOO SU KYOUNGLEE DONG HYUNPARK JAE-HONGLEE JUNG HYUNYIM HYUNG-SOONAN YOUNG JUNLEE KYEONG-WON
C12N 9/90A61K 38/00C12Y 503/04001C07K 14/50C07K 2319/60
58
PatentIndex Score
0
Cited by
7
References
4
Claims

Abstract

A recombinant vector according to an embodiment of the present invention may produce fibroblast growth factor 19 (FGF19) having enhanced solubility. The synonymous codon substitution variant fibroblast growth factor 19 (scvhFGF19) and chaperone ΔssDsbC may be simultaneously and independently expressed in a host cell into which the recombinant vector is introduced, thereby it is possible to overexpress the fibroblast growth factor 19 in a soluble state.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A recombinant vector for inducing soluble expression of fibroblast growth factor 19 (FGF19), the recombinant vector comprising:
 a first polynucleotide which encodes the fibroblast growth factor 19 (FGF19); and 
 a second polynucleotide which encodes disulfide bond isomerase (DsbC), 
 wherein the first polynucleotide consists of the sequence of SEQ ID NO: 3; 
 wherein the second polynucleotide does not comprise a signal sequence; 
 wherein the first polynucleotide and the second polynucleotide are operably linked to different promoters, respectively; and 
 wherein the recombinant vector is designed to introduce into  Escherichia coli.    
 
     
     
       2. The recombinant vector according to  claim 1 , wherein the second polynucleotide encodes a protein consisting of the amino acid sequence of SEQ ID NO: 2. 
     
     
       3. The recombinant vector according to  claim 1 ,
 wherein the second polynucleotide consists of the sequence of SEQ ID NO: 4. 
 
     
     
       4. A method for producing recombinant fibroblast growth factor 19 comprising culturing  Escherichia coli  transformed with the recombinant vector according to  claim 1 .

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.